News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Jill Feldman: Dosing studies are critical!
Photo taken from Jill Feldman/LinkedIn
May 9, 2024, 14:30

Jill Feldman: Dosing studies are critical!

Jill Feldman, Co-Founder of EGFR Resisters, shared a post on X:

“Dosing studies are critical!
OS and QOL both matter and pts/fam are the ONLY ones who can choose what matters most to THEM Amgen Oncology (and many others) please consider alternate doses while doing further studies
PhRMA, please push MED (minimal effective), NOT MTD.”

Read further.
Source: Jill Feldman/X

Amgen Oncology cancer EGFR Resisters Jill Feldman OncoDaily Oncology PhRMA
Special Coverage
Science
Aug 27, 2025, 10:59
Pia Henkel’s Research Reveals How Precision Diagnostics Can Be Scaled Cost-Effectively
Insight
Aug 27, 2025, 10:59
Philippe Guinot will Join Swim4LémanHope Challenge to Support Léman Hope Foundation
Voices
Aug 27, 2025, 10:41
IASLC’s Lung Cancer Considered Podcast Explores ALK+ Summit Highlights and Patient Advocacy
Voices
Aug 27, 2025, 10:20
Ovarian Cancer Research Foundation Highlights Importance of BRCA Testing and Early Detection
Voices
Aug 27, 2025, 10:15
CANCaRe Africa Shares a Life-Changing Story: 3-year-old Kakuru Beats Childhood Cancer
Voices
Aug 27, 2025, 10:11
Jasmine Kamboj Highlights an Eye Opening Podcast with Dr Todd Tuttle on Surgery and Breast Cancer Care
Voices
Aug 27, 2025, 10:07
Julie McCrossin Highlights How Art and Nature Meet in Cancer Care Spaces
Voices
Aug 27, 2025, 09:55
Beau Bosko Toskich Shares Major Milestone in ROWAN Trial Advancing HCC treatment
Voices
Aug 27, 2025, 09:54
Amy Moore Shares Key Insights on Supporting Oncology Teams Through Emotional Burnout
Voices
Aug 27, 2025, 09:45
CancerX Calls to Join a Dynamic Panel Discussion on AI's Impact in Oncology
Voices
Aug 27, 2025, 09:28
NFCR Podcast Features Survivor Story Transforming Melanoma Research
Voices
Aug 27, 2025, 09:10
Moath Ahmad Albliwi: Comparative Outcomes of Intensive Chemotherapy vs Venetoclax + HMA in AML